The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest : a post hoc analysis of the Target Temperature Management trial. / Annborn, Martin; Bro-Jeppesen, John; Nielsen, Niklas; Ullén, Susann; Kjaergaard, Jesper; Hassager, Christian; Wanscher, Michael; Hovdenes, Jan; Pellis, Tommaso; Pelosi, Paolo; Wise, Matt P; Cronberg, Tobias; Erlinge, David; Friberg, Hans; TTM-trial investigators.

In: Intensive Care Medicine, Vol. 40, No. 9, 09.2014, p. 1210-1219.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Annborn, M, Bro-Jeppesen, J, Nielsen, N, Ullén, S, Kjaergaard, J, Hassager, C, Wanscher, M, Hovdenes, J, Pellis, T, Pelosi, P, Wise, MP, Cronberg, T, Erlinge, D, Friberg, H & TTM-trial investigators 2014, 'The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial', Intensive Care Medicine, vol. 40, no. 9, pp. 1210-1219. https://doi.org/10.1007/s00134-014-3375-8

APA

Annborn, M., Bro-Jeppesen, J., Nielsen, N., Ullén, S., Kjaergaard, J., Hassager, C., Wanscher, M., Hovdenes, J., Pellis, T., Pelosi, P., Wise, M. P., Cronberg, T., Erlinge, D., Friberg, H., & TTM-trial investigators (2014). The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial. Intensive Care Medicine, 40(9), 1210-1219. https://doi.org/10.1007/s00134-014-3375-8

Vancouver

Annborn M, Bro-Jeppesen J, Nielsen N, Ullén S, Kjaergaard J, Hassager C et al. The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial. Intensive Care Medicine. 2014 Sep;40(9):1210-1219. https://doi.org/10.1007/s00134-014-3375-8

Author

Annborn, Martin ; Bro-Jeppesen, John ; Nielsen, Niklas ; Ullén, Susann ; Kjaergaard, Jesper ; Hassager, Christian ; Wanscher, Michael ; Hovdenes, Jan ; Pellis, Tommaso ; Pelosi, Paolo ; Wise, Matt P ; Cronberg, Tobias ; Erlinge, David ; Friberg, Hans ; TTM-trial investigators. / The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest : a post hoc analysis of the Target Temperature Management trial. In: Intensive Care Medicine. 2014 ; Vol. 40, No. 9. pp. 1210-1219.

Bibtex

@article{c7ec66a43bdf45ed988839d80825f4d3,
title = "The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial",
abstract = "PURPOSE: We hypothesized that a targeted temperature of 33 °C as compared to that of 36 °C would increase survival and reduce the severity of circulatory shock in patients with shock on admission after out-of-hospital cardiac arrest (OHCA).METHODS: The recently published Target Temperature Management trial (TTM-trial) randomized 939 OHCA patients with no difference in outcome between groups and no difference in mortality at the end of the trial in a predefined subgroup of patients with shock at admission. Shock was defined as a systolic blood pressure of <90 mm Hg for >30 min or the need of supportive measures to maintain a blood pressure ≥90 mmHg and/or clinical signs of end-organ hypoperfusion. In this post hoc analysis reported here, we further analyzed the 139 patients with shock at admission; all had been randomized to receive intervention at 33 °C (TTM33; n = 71) or 36 °C (TTM36; n = 68). Primary outcome was 180-day mortality. Secondary outcomes were intensive care unit (ICU) and 30-day mortality, severity of circulatory shock assessed by mean arterial pressure, serum lactate, fluid balance and the extended Sequential Organ Failure assessment (SOFA) score.RESULTS: There was no significance difference between targeted temperature management at 33 °C or 36 °C on 180-day mortality [log-rank test, p = 0.17, hazard ratio 1.33, 95 % confidence interval (CI) 0.88-1.98] or ICU mortality (61 vs. 44 %, p = 0.06; relative risk 1.37, 95 % CI 0.99-1.91). Serum lactate and the extended cardiovascular SOFA score were higher in the TTM33 group (p < 0.01).CONCLUSIONS: We found no benefit in survival or severity of circulatory shock with targeted temperature management at 33 °C as compared to 36 °C in patients with shock on admission after OHCA.",
keywords = "Aged, Body Temperature, Female, Hospitalization, Humans, Hypothermia, Induced, Male, Middle Aged, Out-of-Hospital Cardiac Arrest, Severity of Illness Index, Shock",
author = "Martin Annborn and John Bro-Jeppesen and Niklas Nielsen and Susann Ull{\'e}n and Jesper Kjaergaard and Christian Hassager and Michael Wanscher and Jan Hovdenes and Tommaso Pellis and Paolo Pelosi and Wise, {Matt P} and Tobias Cronberg and David Erlinge and Hans Friberg and {TTM-trial investigators}",
year = "2014",
month = sep,
doi = "10.1007/s00134-014-3375-8",
language = "English",
volume = "40",
pages = "1210--1219",
journal = "European Journal of Intensive Care Medicine",
issn = "0935-1701",
publisher = "Springer",
number = "9",

}

RIS

TY - JOUR

T1 - The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest

T2 - a post hoc analysis of the Target Temperature Management trial

AU - Annborn, Martin

AU - Bro-Jeppesen, John

AU - Nielsen, Niklas

AU - Ullén, Susann

AU - Kjaergaard, Jesper

AU - Hassager, Christian

AU - Wanscher, Michael

AU - Hovdenes, Jan

AU - Pellis, Tommaso

AU - Pelosi, Paolo

AU - Wise, Matt P

AU - Cronberg, Tobias

AU - Erlinge, David

AU - Friberg, Hans

AU - TTM-trial investigators

PY - 2014/9

Y1 - 2014/9

N2 - PURPOSE: We hypothesized that a targeted temperature of 33 °C as compared to that of 36 °C would increase survival and reduce the severity of circulatory shock in patients with shock on admission after out-of-hospital cardiac arrest (OHCA).METHODS: The recently published Target Temperature Management trial (TTM-trial) randomized 939 OHCA patients with no difference in outcome between groups and no difference in mortality at the end of the trial in a predefined subgroup of patients with shock at admission. Shock was defined as a systolic blood pressure of <90 mm Hg for >30 min or the need of supportive measures to maintain a blood pressure ≥90 mmHg and/or clinical signs of end-organ hypoperfusion. In this post hoc analysis reported here, we further analyzed the 139 patients with shock at admission; all had been randomized to receive intervention at 33 °C (TTM33; n = 71) or 36 °C (TTM36; n = 68). Primary outcome was 180-day mortality. Secondary outcomes were intensive care unit (ICU) and 30-day mortality, severity of circulatory shock assessed by mean arterial pressure, serum lactate, fluid balance and the extended Sequential Organ Failure assessment (SOFA) score.RESULTS: There was no significance difference between targeted temperature management at 33 °C or 36 °C on 180-day mortality [log-rank test, p = 0.17, hazard ratio 1.33, 95 % confidence interval (CI) 0.88-1.98] or ICU mortality (61 vs. 44 %, p = 0.06; relative risk 1.37, 95 % CI 0.99-1.91). Serum lactate and the extended cardiovascular SOFA score were higher in the TTM33 group (p < 0.01).CONCLUSIONS: We found no benefit in survival or severity of circulatory shock with targeted temperature management at 33 °C as compared to 36 °C in patients with shock on admission after OHCA.

AB - PURPOSE: We hypothesized that a targeted temperature of 33 °C as compared to that of 36 °C would increase survival and reduce the severity of circulatory shock in patients with shock on admission after out-of-hospital cardiac arrest (OHCA).METHODS: The recently published Target Temperature Management trial (TTM-trial) randomized 939 OHCA patients with no difference in outcome between groups and no difference in mortality at the end of the trial in a predefined subgroup of patients with shock at admission. Shock was defined as a systolic blood pressure of <90 mm Hg for >30 min or the need of supportive measures to maintain a blood pressure ≥90 mmHg and/or clinical signs of end-organ hypoperfusion. In this post hoc analysis reported here, we further analyzed the 139 patients with shock at admission; all had been randomized to receive intervention at 33 °C (TTM33; n = 71) or 36 °C (TTM36; n = 68). Primary outcome was 180-day mortality. Secondary outcomes were intensive care unit (ICU) and 30-day mortality, severity of circulatory shock assessed by mean arterial pressure, serum lactate, fluid balance and the extended Sequential Organ Failure assessment (SOFA) score.RESULTS: There was no significance difference between targeted temperature management at 33 °C or 36 °C on 180-day mortality [log-rank test, p = 0.17, hazard ratio 1.33, 95 % confidence interval (CI) 0.88-1.98] or ICU mortality (61 vs. 44 %, p = 0.06; relative risk 1.37, 95 % CI 0.99-1.91). Serum lactate and the extended cardiovascular SOFA score were higher in the TTM33 group (p < 0.01).CONCLUSIONS: We found no benefit in survival or severity of circulatory shock with targeted temperature management at 33 °C as compared to 36 °C in patients with shock on admission after OHCA.

KW - Aged

KW - Body Temperature

KW - Female

KW - Hospitalization

KW - Humans

KW - Hypothermia, Induced

KW - Male

KW - Middle Aged

KW - Out-of-Hospital Cardiac Arrest

KW - Severity of Illness Index

KW - Shock

U2 - 10.1007/s00134-014-3375-8

DO - 10.1007/s00134-014-3375-8

M3 - Journal article

C2 - 25001475

VL - 40

SP - 1210

EP - 1219

JO - European Journal of Intensive Care Medicine

JF - European Journal of Intensive Care Medicine

SN - 0935-1701

IS - 9

ER -

ID: 138138634